Proteomedix raises €2.9M Series B round
21 September 2021· Zurich, Switzerland· health, biotech, diagnostics, oncology, b2b, pure_software
Investors
LeadZhejiang Nuhui Health Technology
About Proteomedix
Stage
Series B
Headquarters
Zurich, Switzerland
Founded
2010
Team Size
6–20
Sectors
healthbiotechdiagnosticsoncologyb2bpure_software